IDT AustraliaASX:IDT Days Payable is 157.99 as of Dec. 2025, which is 67% above its 10-year median of 94.39. The stock has 6 warning signs investors should review. Among 920 Drug Manufacturers companies, IDT Australia ranks better than 83.26% on this metric.
The historical rank and industry rank for IDT Australia's Days Payable or its related term are showing as below:
ASX:IDT'
s Days Payable Range Over the Past 10 Years
Min: 41.99 Med: 94.39 Max: 396.94
Current: 190.49
During the past 13 years, IDT Australia's highest Days Payable was 396.94. The lowest was 41.99. And the median was 94.39.
ASX:IDT's Days Payable is ranked better than 83.26% of 920
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs ASX:IDT: 190.49
IDT Australia's Days Payable
increased
from Dec. 2024 (110.26) to Dec. 2025 (157.99).
It may suggest that IDT Australiadelayed paying its suppliers.
IDT Australia Days Payable Related Terms
IDT Australia Days Payable Historical Data
* Premium members only.
The historical data trend for IDT Australia's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, IDT Australia's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDT Australia Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IDT Australia's Days Payable distribution charts can be found below:
* The bar in red indicates where IDT Australia's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
IDT Australia's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDT Australia (ASX:IDT) has a Days Payable of 157.99 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on IDT Australia and its competitors. This is 67% above median its historical median of 94.39. Over the past decade, IDT Australia's Days Payable has ranged from 41.99 to 396.94. According to the industry distribution chart, IDT Australia ranks #154 out of 920 companies in the Drug Manufacturers industry, placing it in the top 16.7%.
Is IDT Australia's Days Payable too high?
IDT Australia's current Days Payable of 157.99 is 67% above median its 10-year median of 94.39. Over the past 10 years, this metric has ranged from a low of 41.99 to a high of 396.94. The Drug Manufacturers industry median Days Payable is 90.84. IDT Australia's value of 157.99 is 73.9% above this industry median. Based on the distribution chart, IDT Australia ranks #154 out of 920 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does IDT Australia's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IDT Australia ranks #154 out of 920 companies for Days Payable. This places IDT Australia in the top 17% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.84. IDT Australia's value of 157.99 is 73.9% above this benchmark. Historically, IDT Australia's own Days Payable has ranged from 41.99 to 396.94 over the past decade. While the company's 10-year median is 94.39 vs. the industry median of 90.84, IDT Australia has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IDT Australia's current Days Payable of 157.99 is 73.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on IDT Australia and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDT Australia's current Days Payable is 157.99, which is 67% above median its own 10-year median of 94.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDT Australia stock overvalued right now?
Based on GuruFocus' analysis, IDT Australia (ASX:IDT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.17, compared to a current price of A$0.03 — trading 80.6% below its estimated fair value. The current Days Payable is 157.99, which is 67% above median its 10-year median of 94.39 and 73.9% above the Drug Manufacturers industry median of 90.84. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For IDT Australia (ASX:IDT), the current Days Payable is 157.99 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services. The company operates in Australia, Asia, Europe, and the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:IDT has been successfully added to your 